Cell And Tissue Analysis Products: The Global Market
September 18, 2009
Wellesley, Mass. – According to a new technical market research report, CELL AND TISSUE ANALYSIS PRODUCTS: THE GLOBAL MARKET (BIO068A) from BCC Research (www.bccresearch.com), the global market for cell and tissue analysis products was worth $2.6 billion in 2008 and an estimated $2.8 billion in 2009. This will increase to nearly $4.5 billion in 2014, for a compound annual growth rate (CAGR) of 10.1%.
The market is broken down into segments of cell and tissue characterization products, biospecimens, cell separation products. The cell and tissue characterization products segment is the largest of the three, generating $1.2 billion in 2008 and an estimated $1.3 billion in 2009. This should reach $2.2 billion in 2014, for a CAGR of 10.8%.
The cell separation products segment is a close second in value, with $1.2 billion in sales in 2008 and an estimated $1.3 billion in 2009. That is expected to grow to $2.1 billion in 2014, for a CAGR of 9.8%. The biospecimens segment is expected to generate $132 million in 2014.
SUMMARY FIGURE
GLOBAL MARKET FOR CELL AND TISSUE ANALYSIS PRODUCTS, BY SEGMENT, 2008-2014
($ MILLIONS)
To Contact us, click here 
Source: BCC Research
The recent surge in NIH and NSF funding, $10.4 billion and $3 billion, respectively, stemming from President Obama’s stimulus package, will serve to drive novel and existing domestic research programs. As innovative projects get underway and new proposals are developed, the acute demand for products associated with life-science research will increase accordingly. As a corollary, due to the central role of cell and tissue analysis products in the life-science research flow, this market report will be particularly timely.
The study scope of this report includes commercialized products used in the isolation, purification and analysis of cells, as well as novel products that may be commercially viable by 2014.
This report will be of general interest to business professionals in the field of biotechnology. Both life-science reagent suppliers and research scientists will benefit from the comprehensive summary of relevant technologies and industrial profiles contained in the study.
Cell and Tissue Analysis Products: The Global Market( BIO068A )
Publish Date: Sep 2009
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
Cell and Tissue Analysis Products: The Global Market
Customize This Report More in Cell Biology
- Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand
- Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
- AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand
- Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development
Reports from Cell Biology
Recent News
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum